Skip to content

EMDR Psychotherapy for Anxious-depressive Symptoms in Breast Cancer Patient

EMDR Psychotherapy of Anxious-depressive Symptoms for Women That Present an Invasive Breast Cancer : a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03898453
Acronym
PSYCANCER
Enrollment
64
Registered
2019-04-02
Start date
2019-03-11
Completion date
2023-09-24
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female

Keywords

Breast Cancer, support psychotherapy, EMDR therapy, anxiety disorders

Brief summary

The study will consist in an evaluation of the EMDR (Eye Movement Desensitization and Reprocessing) psychotherapy in the context on invasive primitive breast cancer. EMDR could then allow the affected patients to readjust their point of view on the pathology and thus promote more adapted behaviors or additional resources to cope with the disease. 190 Patients are going to be randomized in two groups : one group with EMDR psychotherapists and one group with support psychotherapists. Patients will receive 8 sessions. We expect that patient in EMDR psychotherapists group will have an higher decrease of anxiety score, depressive score (CES-D) and PTSD score, and a higher increase in quality of life.

Detailed description

The study will consist in an evaluation of the EMDR psychotherapy in the context on invasive primitive breast cancer. EMDR could then allow the affected patients to readjust their point of view on the pathology and thus promote more adapted behaviors or additional resources to cope with the disease. 190 Patients are going to be randomized in two groups : one group with EMDR psychotherapists and one group with support psychotherapists. Patients will receive 8 sessions. We expect that patient in EMDR psychotherapists group will have an higher decrease of anxiety score, depressive score and PTSD score, and a higher increase in quality of life (QLQ)

Interventions

Visit 0 : patient inclusion (questionnaires and interview) Visit 1 : anamnesis Visit 2 : patient stabilisation Visit 3 : EMDR psychotherapy care Visit 4 : EMDR psychotherapy care Visit 5 : EMDR psychotherapy care and questionnaires Visit 6 : EMDR psychotherapy care Visit 7 : EMDR psychotherapy care and questionnaires Follow-up 8 (three month after) : data recovery (questionnaires) Follow-up 9 (six month after) : data recovery (questionnaires)

BEHAVIORALsupport psychotherapy

Visit 0 : patient inclusion (questionnaires and interview) Visits 1-7: several methods could be used: psychoeducation about cancer and psychotherapy, positive interaction and activity schedule, emotional support , relaxation, prevention techniques… Questionnaires will be completed by patients at visit 5 and 7. Follow-up 8 (one month after) : data recovery (questionnaires) Follow-up 9 (six month after) : data recovery (questionnaires)

Sponsors

University of Lorraine
CollaboratorOTHER
Central Hospital, Nancy, France
CollaboratorOTHER
Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Two groups assignment - One group will receive EMDR psychotherapy the other one support psychotherapy.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Being a 18 or more year old woman * Having primary breast cancer or going to start treatment or having completed treatments for less than 6 months * Presenting a state-anxiety level a score higher than 35. * Being able to complete questionnaires. * Having signed the consent letter * Be affiliated to a social security system

Exclusion criteria

* Have contraindications for EMDR psychotherapy (neurological disorders, dissociative states, oculomotor problems) * Have metastatic breast cancer * physical multiple pathologies * Have a psychiatric history (including anxio-depressive disorders). Background Assessment from M.I.N.I. (Sheehan et al., 1997) * Present an addiction, an abuse of drugs or alcohol * Person placed under the protection of justice, guardianship or trusteeship. * Pregnant or lactating woman

Design outcomes

Primary

MeasureTime frameDescription
State AnxietyMonth 9STAI-Y-A (State-Trait Anxiety Inventory) This questionnaire consists of a 20-items. The state version (STAI Y-A) indicate for 20 items and on 4-point Likert-Scale (not at all, somewhat, moderately so, and very much so) the extent to which they are currently experiencing each symptoms of anxiety. The total score ranges from 20 to 80. A higher total score indicate a higher level of anxiety.

Secondary

MeasureTime frameDescription
quality of life of cancer patientsMonth 9EORTC QLQ-C30 Questionnaire The European Organization for research and Treatment of Cancer 30-item Quality of life (QoL) questionnaire is a well-validated health-related QoL instrument.
depressionMonth 9CES-D (The Center for Epidemiologic Studies Depression) Questionnaire
posttraumatic symptomsMonth 9PTGI (The Posttraumatic Growth Inventory) Questionnaire

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026